Literature DB >> 29899004

Performance Validation of Selective Screening Agars for Guiding Antimicrobial Prophylaxis in Patients Undergoing Prostate Biopsy.

Sofie C M Tops1, Marlie Bruens2, Sacha van Mook-Vermulst2, Diane Lamers-Jansen2, Tobias Engel2, Ger van den Brink3, Rob van Duuren3, Heiman F L Wertheim2, Eva Kolwijck2.   

Abstract

A rectal culture-guided antimicrobial prophylaxis strategy may prevent infections after transrectal ultrasound-guided prostate biopsy (TRUSP). The use of selective culture media could assist the choice of appropriate antibiotic prophylaxis. The objective of our study was to evaluate the performance of four selective media used for guidance of oral antibiotic prophylaxis in TRUSP. In this prospective validation study, we used MacConkey media with vancomycin plus one of the following antibiotics: ciprofloxacin (McC3+CIP/V), trimethoprim (McC3+TMP/V), fosfomycin (McC3+FOF/V), and amdinocillin-amoxicillin-clavulanic acid (McC3+MEC/V). First, clinical strains of Gram-negative bacilli (GNB) (n = 33) were evaluated for growth on the selective media. Thereafter, rectal swabs (n = 97) were randomly collected from residual material of fresh stool samples and plated on a growth control and the four selective media. Levels of recovery of GNB on the growth control and selective media were compared, and the MICs of the antibiotics used in this study were determined. The sensitivity and specificity of the four selective media amounted, respectively, to 90.0% (55.5 to 99.8%) and 98.7% (93.1 to 100.0%) for McC3+CIP/V, 95.7% (85.2 to 99.5%) and 100.0% (91.6 to 100.0%) for McC3+TMP/V, 95.5% (84.5 to 99.4%) and 97.8% (88.2 to 99.9%) for McC3+FOF/V, and 100.0% (76.8 to 100.0%) and 97.6% (87.4 to 99.9%) for McC3+MEC/V. In conclusion, the four selective media were sufficiently sensitive and specific for the identification of rectal GNB resistant to ciprofloxacin, trimethoprim, fosfomycin, or amdinocillin-amoxicillin-clavulanic acid. These media can have added value in streamlining the optimal culture based antibiotic prophylaxis in TRUSP in a non-labor-intensive manner.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antibiotic prophylaxis; performance; selective culture media; susceptibility testing of Gram-negative bacilli; validation

Mesh:

Substances:

Year:  2018        PMID: 29899004      PMCID: PMC6113462          DOI: 10.1128/JCM.00253-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Authors:  Niki Lampri; Irene Galani; Garyphallia Poulakou; Ioannis Katsarolis; George Petrikkos; Helen Giamarellou; Maria Souli
Journal:  J Antimicrob Chemother       Date:  2012-06-04       Impact factor: 5.790

2.  Serum concentrations and penetration into prostate of mecillinam and ampicillin.

Authors:  N Jeppesen; C Frimodt-Møller
Journal:  Curr Med Res Opin       Date:  1984       Impact factor: 2.580

3.  Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.

Authors:  Michael A Liss; Stephen A Taylor; Deepak Batura; Deborah Steensels; Methee Chayakulkeeree; Charlotte Soenens; G Gopal Rao; Atreya Dash; Samuel Park; Nishant Patel; Jason Woo; Michelle McDonald; Unwanaobong Nseyo; Pooya Banapour; Stephen Unterberg; Thomas E Ahlering; Hendrik Van Poppel; Kyoko Sakamoto; Joshua Fierer; Peter C Black
Journal:  J Urol       Date:  2014-06-10       Impact factor: 7.450

4.  Rectal swab culture-directed antimicrobial prophylaxis for prostate biopsy and risk of postprocedure infection: a cohort study.

Authors:  Jessica Dai; Andrew Leone; Leonard Mermel; Kathleen Hwang; Gyan Pareek; Stephen Schiff; Dragan Golijanin; Joseph F Renzulli
Journal:  Urology       Date:  2014-11-20       Impact factor: 2.649

5.  The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.

Authors:  Sakir Ongün; Güven Aslan; Vildan Avkan-Oguz
Journal:  Urol Int       Date:  2012-09-22       Impact factor: 2.089

6.  Comparative Effectiveness of Single versus Combination Antibiotic Prophylaxis for Infections after Transrectal Prostate Biopsy.

Authors:  Kaylee Marino; Anne Parlee; Ralph Orlando; Lori Lerner; Judith Strymish; Kalpana Gupta
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

7.  Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.

Authors:  D A Kapoor; I W Klimberg; G H Malek; J D Wegenke; C E Cox; A L Patterson; E Graham; R M Echols; E Whalen; S F Kowalsky
Journal:  Urology       Date:  1998-10       Impact factor: 2.649

8.  Impact of preoperative screening for rectal colonization with fluoroquinolone-resistant enteric bacteria on the incidence of sepsis following transrectal ultrasound guided prostate biopsy.

Authors:  John J Farrell; Jennifer L Hicks; Stephanie E Wallace; Allen D Seftel
Journal:  Res Rep Urol       Date:  2017-02-24

Review 9.  Prevalence, Risk Factors, and Clinical Relevance of Fluoroquinolone-Resistant Organisms in Rectal Cultures: Should We Target Antibiotic Prophylaxis Prior to Prostate Biopsy?

Authors:  J Van Besien; P Uvin; A M Van den Abeele; L Merckx
Journal:  Adv Urol       Date:  2016-03-01

10.  Fosfomycin antimicrobial prophylaxis for transrectal ultrasound-guided biopsy of the prostate: A prospective randomised study.

Authors:  Ahmed M Fahmy; Ahmed Kotb; Tamer Abo Youssif; Hussien Abdeldiam; Omer Algebaly; Ahmed Elabbady
Journal:  Arab J Urol       Date:  2016-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.